JP1520 PIK3CA WT HA Citations (3)

Originally described in: Breast cancer-associated PIK3CA mutations are oncogenic in mammary epithelial cells.
Isakoff SJ, Engelman JA, Irie HY, Luo J, Brachmann SM, Pearline RV, Cantley LC, Brugge JS Cancer Res. 2005 Dec 1. 65(23):10992-1000. PubMed Journal

---

Articles Citing JP1520 PIK3CA WT HA

Articles
Repression of cancer cell senescence by PKCiota. Paget JA, Restall IJ, Daneshmand M, Mersereau JA, Simard MA, Parolin DA, Lavictoire SJ, Amin MS, Islam S, Lorimer IA. Oncogene. 2012 Aug 2;31(31):3584-96. doi: 10.1038/onc.2011.524. Epub 2011 Nov 28. PubMed
The adherens junction protein afadin is an AKT substrate that regulates breast cancer cell migration. Elloul S, Kedrin D, Knoblauch NW, Beck AH, Toker A. Mol Cancer Res. 2014 Mar;12(3):464-76. doi: 10.1158/1541-7786.MCR-13-0398. Epub 2013 Nov 22. PubMed
Aspirin suppresses growth in PI3K-mutant breast cancer by activating AMPK and inhibiting mTORC1 signaling. Henry WS, Laszewski T, Tsang T, Beca F, Beck AH, McAllister SS, Toker A. Cancer Res. 2016 Dec 9. pii: canres.2400.2016. PubMed

If you have published an article using this material, please email us at to have your article added to this page.